IVERS-READ GILLIAN C (See Remarks) sold 1.3% of their position (3.73K shares) of CLOVIS ONCOLOGY, INC. on the open market
Open‑market sale worth $7.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/3/2022ACC: 0000899243-22-016297
Officer· See Remarks
Since Sep 2018
-3.73K
Net shares
Net seller
$7.4K
Total sold
2
Open market trades
0B · 2S
6
Total transactions
8.37K acquired · 12.11K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+3.75K
Price / share
—
Trade value
—
% of position
1.4%
5/1/2022
274.14K→277.89K
Common Stock
Direct
Shares
+4.63K
Price / share
—
Trade value
—
% of position
1.7%
5/1/2022
276.22K→280.85K
Common Stock
Direct
Shares
−1.67K
Price / share
$1.97
Trade value
$3.29K
% of position
0.6%
5/2/2022
277.89K→276.22K
Common Stock
Direct
Shares
−2.06K
Price / share
$1.97
Trade value
$4.06K
% of position
0.7%
5/2/2022
280.85K→278.78K
Total
Net shares
+4.64K
Net value
-$7.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/1/2022 | M · Option Exercise | +3.75K | — | — | 1.4% | 274.14K | 277.89K |
| Common Stock Direct | 5/1/2022 | M · Option Exercise | +4.63K | — | — | 1.7% | 276.22K | 280.85K |
| Common Stock Direct | 5/2/2022 | S · Sale | −1.67K | $1.97 | $3.29K | 0.6% | 277.89K | 276.22K |
| Common Stock Direct | 5/2/2022 | S · Sale | −2.06K | $1.97 | $4.06K | 0.7% | 280.85K | 278.78K |
| Total | +4.64K | -$7.35K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
3.75K shares
Shares
−3.75K
Strike price
Held after
11.25K
Exercisable
—
5/1/2022
Restricted Stock Units
Direct
Converts to
Common Stock
4.63K shares
Shares
−4.63K
Strike price
Held after
32.38K
Exercisable
—
5/1/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock3.75K shares | 5/1/2022 | M · Option Exercise | −3.75K | — | 11.25K | |
| Restricted Stock Units Direct | Common Stock4.63K shares | 5/1/2022 | M · Option Exercise | −4.63K | — | 32.38K |